Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DR26FHGS8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,006
Award facts
- Contract value 100% obligated
- $17,005.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,005.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by December 3, 2025. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and will serve as the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion federal acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. DMS Pharmaceutical Group's established track record supplying diverse pharmaceutical products—ranging from oncology treatments and biologics to routine medications and specialty medical devices—demonstrates its capability to fulfill the specialized pharmaceutical requirements of the military medical system through this strategic prime vendor arrangement.
Quick answers
Who was awarded contract SPE2DR26FHGS8?
SPE2DR26FHGS8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FHGS8 worth?
The government has obligated $17,006 on SPE2DR26FHGS8.
Is contract SPE2DR26FHGS8 an order under another contract?
Yes. SPE2DR26FHGS8 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGS8 competed?
The extent of competition for SPE2DR26FHGS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award